Expression Data from 226 patients of the REMAGUS02 trial
Identification of predictive markers of response to treatment is a major objective in breast cancer. A major problem in clinical sampling is the variability of RNA templates, requiring accurate management of tumour material and subsequent analyses for future translation in clinical practice. Our aim was to establish the feasibility and reliability of high throughput RNA analysis in a prospective trial. Our data showed that strict quality criteria for RNA integrity assessment and well calibrated...
Provenance — who produced it, who reused it
Linked to 13 papers in the literature. Roles are inferred factual signals (who deposited the data vs who reused it), with counts — never a judgement about any author.
- Amplification and high-level expression of heat shock protein 90... 2012 · 183 cites
- EMT is associated with an epigenetic signature of ECM remodeling... 2019 · 148 cites
- DEAD-box helicase DP103 defines metastatic potential of human br... 2014 · 131 cites
- SPHK1 regulates proliferation and survival responses in triple-n... 2014 · 73 cites
9 further papers cite this accession but reuse could not be confirmed.
Deep data QC
metadata only · no data-level QC for this typeStandardized, field-standard QC computed by touching the data — every metric states how it was obtained
measured = computed from the data · extrapolated/reported = derived or from the repository · dq-1.0 · provisional — verify independently